Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02213926 |
|---|---|
| Brief Title: | An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma |
| First Submitted : | August 5, 2014 |
| First Submitted that Met QC Criteria : | August 11, 2014 |
| First Posted : | August 12, 2014 (Estimate) |
| Results First Submitted : | August 16, 2018 |
| Results First Submitted that Met QC Criteria : | October 18, 2018 |
| Results First Posted : | October 19, 2018 |
| Last Update Submitted that Met QC Criteria : | January 19, 2024 |
| Last Update Posted : | January 23, 2024 |